<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00916955</url>
  </required_header>
  <id_info>
    <org_study_id>3669FF</org_study_id>
    <nct_id>NCT00916955</nct_id>
  </id_info>
  <brief_title>Genetic Modifiers for 22q11.2 Syndrome</brief_title>
  <acronym>VCFS</acronym>
  <official_title>Genetic Modifiers for 22q11.2 Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>State University of New York - Upstate Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Albert Einstein College of Medicine, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>State University of New York - Upstate Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the project is the determination of how the deletion of DNA from chromosome 22
      at the q11.2 band causes the phenotypes observed in velo-cardio-facial syndrome (VCFS). In
      other words, the purpose remains genotype-to-phenotype matching. Current methods includes the
      use of whole genome chips and microarray analysis. Blood samples are collected for DNA from
      every patient who consents from the VCFS Center at Upstate Medical University. They are
      examined for phenotypic features consistent with our typical clinical evaluation. The
      information from these examinations will be entered anonymously into a database. Genomic
      information is then matched to clinical phenotype with appropriate statistical method
      applied.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2008</start_date>
  <completion_date type="Anticipated">February 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>gene signal strength</measure>
    <time_frame>4 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>physical phenotype</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>22q11.2 Deletion Syndrome</condition>
  <arm_group>
    <arm_group_label>Individuals with 22q11.2 deletions</arm_group_label>
    <description>Individuals confirmed with the diagnosis of velo-cardio-facial syndrome by positive FISH or CGH microarray confirming the diagnosis and deletion of 22q11.2</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observation</intervention_name>
    <description>Observe development of syndrome over time</description>
    <arm_group_label>Individuals with 22q11.2 deletions</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      peripheral blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All individuals with velo-cardio-facial syndrome confirmed by FISH
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  FISH confirmed diagnosis of 22q11.2 deletion syndrome

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert J Shprintzen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Upstate Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bernice Morrow, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Albert Einstein College of Medicine, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne Marie Higgins, RN, FNP, MA</last_name>
    <phone>315-464-6595</phone>
    <email>HigginsA@upstate.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Robert J Shprintzen, PhD</last_name>
    <phone>315-464-6590</phone>
    <email>shprintr@upstate.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>VCFS International Center</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Marie Higgins, RN, FNP, MA</last_name>
      <phone>315-464-6595</phone>
      <email>HigginsA@upstate.edu</email>
    </contact>
    <contact_backup>
      <last_name>Robert J Shprintzen, PhD</last_name>
      <phone>315-464-6590</phone>
      <email>shprintr@upstate.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.vcfscenter.org</url>
    <description>Web site of the location for the investigation</description>
  </link>
  <results_reference>
    <citation>Shprintzen RJ, Higgins AM, Antshel K, Fremont W, Roizen N, Kates W. Velo-cardio-facial syndrome. Curr Opin Pediatr. 2005 Dec;17(6):725-30. Review.</citation>
    <PMID>16282778</PMID>
  </results_reference>
  <verification_date>August 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 24, 2008</study_first_submitted>
  <study_first_submitted_qc>June 8, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 10, 2009</study_first_posted>
  <last_update_submitted>January 5, 2015</last_update_submitted>
  <last_update_submitted_qc>January 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 6, 2015</last_update_posted>
  <responsible_party>
    <name_title>Bernice Morrow, Ph.D.</name_title>
    <organization>Albert Einstein College of Medicine</organization>
  </responsible_party>
  <keyword>22q11.2 deletion syndrome</keyword>
  <keyword>velo-cardio-facial syndrome</keyword>
  <keyword>congenital anomalies</keyword>
  <keyword>mental illness</keyword>
  <keyword>congenital heart disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>DiGeorge Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

